EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Jun-2026 04:15 ET (20-Jun-2026 08:15 GMT/UTC)

EDCs found in breast milk and infant urine up to age 6 months

The Endocrine Society
Reports and Proceedings

Endocrine-disrupting chemicals (EDCs) that interfere with hormones were found in breast milk and in the urine of children from birth up to 6 months, according to a study being presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Ill.

Meeting: ENDO 2026

Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy

The Endocrine Society
Reports and Proceedings

Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study being presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Ill. The research suggests reproductive and hormonal factors may be involved in thyroid carcinogenesis.

Dana-Farber research supports FDA approval of pembrolizumab-belzutifan combination for higher-risk clear cell kidney cancer after surgery

Dana-Farber Cancer Institute
Business Announcement

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions. The approval is based on results from the phase 3 LITESPARK-022 trial, led by Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute.

This is how to beat the tumor cells that survive cancer therapy

University of California - San Francisco
Peer-Reviewed Publication

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These “persister” cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment.

Journal: Science Advances
Funder: Mark Foundation For Cancer Research, California Institute for Quantitative Biosciences

Montana State researcher discovers a critical cellular system that may one day lead to treatment of some cancers

Montana State University
Peer-Reviewed Publication

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – the creation of the amino acid cysteine within a living cell when the cell’s primary systems to do so fail. The discovery may one day lead to new cancer treatments.

Journal: Nature Chemical Biology

University of Oklahoma receives $11.5 million NIH award to establish statewide immunoengineering research center

University of Oklahoma
Grant and Award Announcement

The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the Oklahoma Center of ImmunoEngineering, a new research center designed to accelerate the study and treatment of diseases rooted in the immune system.

Sorting cells’ inner structures provides new path to drug development

Princeton University, Engineering School
Peer-Reviewed Publication

A study published in Cell advances understanding of how drugs shape vital cellular structures known as biomolecular condensates, blob-like mechanisms that drive gene regulation processes and have been linked to Alzheimer's, ALS and cancer.

Journal: Cell
Funder: Howard Hughes Medical Institute

Health equity after a colorectal cancer screening program

JAMA Network
Peer-Reviewed Publication

About The Study: In this cross-sectional study, following the implementation of an organized population screening program, colorectal cancer screening participation increased and socioeconomic disparities narrowed over time. Overall uptake in Hong Kong remains low, and some disparities persist in younger age groups (age 50-59 years), single households, individuals with a primary and secondary school education, lower-income groups, and public housing residents. Efforts to increase participation are needed in certain groups to ensure health equity.

Journal: JAMA Health Forum

Metal-free carbon monoxide prodrugs may help prevent cancer’s deadly spread

Weill Cornell Medicine
Peer-Reviewed Publication

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine. The recent preclinical study, published in Advanced Science, offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.

Journal: Advanced Science

From cellular subtypes to virtual tumor: A single-cell atlas of the tumor microenvironment

Immunity & Inflammation
Peer-Reviewed Publication

Tumor cells coexist with diverse immune, stromal, and neural cells in a complex microenvironment. Recent single-cell and spatial transcriptomics have uncovered specialized cell subsets that drive cancer progression, immune evasion, and treatment response. A new review synthesizes these advances, introduces the “virtual tumor” concept for AI-driven ecosystem modeling, and outlines a roadmap from fundamental tumor microenvironment (TME) biology to next-generation precision immunotherapies targeting specific cell populations and their coordinated networks.

Journal: Immunity & Inflammation

5
6
7
8
9